Medication info
Memantine Tablets 20 mg (Memantine Hydrochloride)

Memantine Tablets 20 mg (Memantine Hydrochloride)

Prescription medicationTabletOral
Ingredient · strength
Memantine Hydrochloride›20mg / 1 tablet
Manufacturer / importer
Dongkuk Pharmaceutical Co., Ltd.
Appearance
Pink oval film-coated tablets
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 202400461 · Approved 2024.03.05 · Insurance code 653405580

Summary

Main use
Treatment of moderate to severe Alzheimer's disease
Who takes it
Adults
Adult dose
Administer this medicine orally once daily, at the same time each day. If necessary, it may be administered twice daily. It may be taken with or without food. 1. Adults Dose escalation: The maximum daily dose is 20 mg. To minimize the risk of adverse reactions, increase the dose by 5 mg per week over the first 3 weeks as follows to reach the maintenance dose. Week 1 (Days 1–7): Administer 5 mg once daily for 7 days. Week 2 (Days 8–14): Administer 10 mg once daily for 7 days. Week 3 (Days 15–21): Administer 15 mg once daily for 7 days. From Week 4 onward, administer 20 mg once daily. Maintenance dose: The recommended maintenance dose is 20 mg once daily. 2. Elderly patients Based on clinical data, the recommended dose for elderly patients aged 65 years and older is 20 mg once daily. 3. Patients with renal impairment No dose adjustment is necessary in patients with mild renal impairment (creatinine clearance: 50-80 mL/min). In patients with moderate renal impairment (creatinine clearance: 30-49 mL/min), reduce the daily dose to 10 mg. If well tolerated for at least 7 days after administration, the dose may be increased to 20 mg once daily according to the standard dose-escalation schedule. In patients with severe renal impairment (creatinine clearance: 5-29 mL/min), reduce the daily dose to 10 mg. 4. Patients with hepatic impairment No dose adjustment is necessary in patients with mild or moderate hepatic impairment (Child-Pugh A, Child-Pugh B). Since there are no data on the use of memantine in patients with severe hepatic impairment, it is preferable not to administer this medicine.

Ingredients

Manufacturer
Dongkuk Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of moderate to severe Alzheimer's disease

View approved original text

This medication is used for the treatment of moderate to severe Alzheimer's disease. It can help improve memory decline and cognitive function impairment in patients. It aids in daily functioning and can slow the progression of the disease. Continuous use can contribute to the improvement of the patient's quality of life.

How to take

Adult dose

Administer this medicine orally once daily, at the same time each day. If necessary, it may be administered twice daily. It may be taken with or without food. 1. Adults Dose escalation: The maximum daily dose is 20 mg. To minimize the risk of adverse reactions, increase the dose by 5 mg per week over the first 3 weeks as follows to reach the maintenance dose. Week 1 (Days 1–7): Administer 5 mg once daily for 7 days. Week 2 (Days 8–14): Administer 10 mg once daily for 7 days. Week 3 (Days 15–21): Administer 15 mg once daily for 7 days. From Week 4 onward, administer 20 mg once daily. Maintenance dose: The recommended maintenance dose is 20 mg once daily. 2. Elderly patients Based on clinical data, the recommended dose for elderly patients aged 65 years and older is 20 mg once daily. 3. Patients with renal impairment No dose adjustment is necessary in patients with mild renal impairment (creatinine clearance: 50-80 mL/min). In patients with moderate renal impairment (creatinine clearance: 30-49 mL/min), reduce the daily dose to 10 mg. If well tolerated for at least 7 days after administration, the dose may be increased to 20 mg once daily according to the standard dose-escalation schedule. In patients with severe renal impairment (creatinine clearance: 5-29 mL/min), reduce the daily dose to 10 mg. 4. Patients with hepatic impairment No dose adjustment is necessary in patients with mild or moderate hepatic impairment (Child-Pugh A, Child-Pugh B). Since there are no data on the use of memantine in patients with severe hepatic impairment, it is preferable not to administer this medicine.

Precautions

This medication should not be taken by individuals who are allergic to its components. It is also not safe for those with severely impaired liver function or serious kidney dysfunction. Caution is required for individuals with epilepsy or a history of seizures. Particularly, concomitant use of drugs affecting the NMDA receptor, such as amantadine, ketamine, or dextromethorphan, can aggravate side effects, so they should not be taken together. Attention is also needed in cases of changing urine acidity or specific urinary tract infections as these may affect the medication’s efficacy or side effects. Patients with unregulated heart diseases or hypertension should use this medication cautiously. Side effects such as dizziness, headache, constipation, drowsiness, and elevated blood pressure may occur, most of which are mild to moderate. Neurological side effects, such as confusion, hallucinations, or seizures, may rarely occur, and if symptoms arise, immediate consultation with medical personnel is necessary. This medication can interact with other drugs, and caution is required in particular when taking it with other NMDA receptor-affecting drugs, antipsychotics, or skeletal muscle relaxants. Pregnant women should only take this medication if absolutely necessary as safety for the fetus has not been established, and breastfeeding women are advised to discontinue breastfeeding as this medication may be excreted in breast milk. The safety and efficacy of this medication have not been confirmed in children or adolescents under 18 years. Overdose may result in central nervous system and gastrointestinal symptoms such as confusion, drowsiness, dizziness, and vomiting, and in such cases, appropriate treatment should be sought immediately. This medication may affect the patient’s response speed and concentration, so caution is needed when driving or operating machinery. It should be kept out of reach of children, and transferring it to another container may pose a risk of accidents or quality deterioration.

Side effects

  • Dizziness
  • headache
  • constipation
  • drowsiness
  • hypertension
  • fungal infection
  • drug hypersensitivity reaction
  • drowsiness
  • confusion
  • hallucination
Show 32 more
  • psychotic reaction
  • dizziness
  • balance disorder
  • gait abnormality
  • seizure
  • heart failure
  • hypertension
  • venous thrombosis/thromboembolism
  • dyspnea
  • constipation
  • vomiting
  • pancreatitis
  • elevated liver function test results
  • hepatitis
  • headache
  • fatigue
  • sense of fatigue
  • weakness
  • diarrhea
  • confusion
  • drowsiness
  • anxiety
  • aggression
  • hallucination
  • gait disorder
  • restlessness
  • psychosis
  • visual hallucination
  • convulsion
  • drowsiness
  • confusion
  • unconsciousness

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to prevent air or moisture ingress. It is advisable to maintain the storage temperature between 1°C and 30°C at room temperature. Storing it this way can help maintain the drug’s efficacy over time.

Appearance and packaging

Appearance

Pink oval film-coated tablets

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.